Ecopipam reduces tics in children with Tourette syndrome
1. In a phase 2 trial of patients with Tourette syndrome, ecopipam, a selective dopamine receptor antagonist, was associated with a ...
1. In a phase 2 trial of patients with Tourette syndrome, ecopipam, a selective dopamine receptor antagonist, was associated with a ...
1. No significant differences in tic severity were found between deutetrabenazine and placebo after 8 weeks of treatment, despite a ...
Individuals with Tourette syndrome (TS) and other chronic tic disorders (CTD) are at an increased of developing cardiometabolic disorders, in ...
Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders Individuals with Tourette syndrome (TS) and other ...
Originally published by Harvard Health. What Is It? Tourette syndrome (TS) is a problem of the nervous system that was ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.